Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Nurses' attitudes regarding the importance of families in nursing care: a cross-sectional study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. 'Wow I had no idea' - How job rotation is experienced by nurses caring for elective orthopaedic patients: A qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Are cancer patients better off if they participate in clinical trials? A mixed methods study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The culture of hope and ethical challenges in clinical trials: A qualitative study of oncologists and haematologists’ views

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS AND OBJECTIVES: To examine cancer patients' perceptions of factors that may influence their decisions on participating in phase I-III clinical drug trials.

BACKGROUND: The number of cancer participants in clinical drug trials has increased rapidly in Denmark in recent years. The rights, safety and well-being of patients considering participation are protected by the international, ethical and scientific principles. A meta-synthesis was conducted to enable health professionals to support cancer patients who are considering trial participation in accordance with the above principles.

DESIGN: Meta-synthesis.

METHODS: A qualitative meta-synthesis, as described by Sandelowski and Barroso, was conducted based on a literature search in PubMed, CINAHL, EMBASE and PsycINFO. Nine reports were found eligible and were included. The PRISMA checklist was used.

RESULTS: A framework was developed, and patients' perceptions of the factors influencing their decisions were identified, namely patients' perceptions of their relatives, the physician, the hope of therapeutic benefit, altruism, having other options and living with cancer.

CONCLUSIONS: This study shows that cancer patients' decisions on participation in clinical drug trials are influenced by their perceptions of trust towards the physician, their relatives' attitudes and the consequences participation might have for their families. Patients are motivated to participate due to the hope of therapeutic benefit and for altruistic reasons. The factors influencing their decisions to participate include a cost-benefit consideration, which in turn may be subject to the patient's perception of having other options available besides participation. This may be related to the patient's attitude towards living with cancer, and the decision can be a way of trying to cope with the psychological aspects of living with cancer.

RELEVANCE TO CLINICAL PRACTICE: The results of this meta-synthesis offer insight into patients' perceptions of what may influence their decisions, and they enable health professionals to support patients making such decisions.

Original languageEnglish
JournalJournal of Clinical Nursing
Volume28
Issue number13-14
Pages (from-to)2443-2461
Number of pages19
ISSN0962-1067
DOIs
Publication statusPublished - 1 Jul 2019

    Research areas

  • altruism, attitude, clinical trial, hope, motivation, neoplasms, nurses, patients, physicians

ID: 57210504